Synthego

Robert Deans, Ph.D., Chief Scientific Officer

Oct. 14 | 11:45am | BlueRock Therapeutics Ballroom

Redwood City, CA
(Private)

In-person Presentation
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s platform technologies vertically integrate proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance basic research, target validation, and clinical trials. With its technologies cited in hundreds of peer-reviewed publications and utilized by thousands of commercial and academic researchers and therapeutic drug developers, Synthego is at the forefront of innovation enabling the next generation of medicines by delivering genome editing at an unprecedented scale.
www.synthego.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions